Prognostic Significance of the CALM Index in Surgically Resected Non-Small Cell Lung Cancer
Journal of Clinical Medicine · 23.07.2026 · 15 (15) · 5772
DOI: 10.3390/jcm15155772 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.07.2026. Verfasst von Soomin An und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Dongyang University, Yeongju 36040, Gyeongbuk, Republic of Korea. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dongyang University.
Abstract (Originalsprache)
Background
Anatomical staging is often insufficient for predicting outcomes in stage I-IIIA non-small cell lung cancer (NSCLC) patients after curative resection due to inherent prognostic variability. In this study, we evaluated the prognostic value of the C-reactive protein–albumin–lymphocyte–monocyte (CALM) index as an integrative biomarker for overall survival (OS).
Methods
This retrospective study included 533 patients with stage I-IIIA NSCLC. We assessed the association between the CALM index and OS using multivariable Cox proportional hazards models, adjusted for established clinicopathological factors. We employed LASSO-penalized regression to optimize variable selection and ensure model stability. Comprehensive performance metrics were calculated, including Harrell’s C-index, integrated area under the curve (iAUC), integrated discrimination improvement (IDI), and decision-curve analysis (DCA).
Results
The CALM index was identified as a stable, independent predictor of OS across both conventional and LASSO-penalized models. The final multivariable model incorporated the CALM index alongside age, pathological stage, American Society of Anesthesiologists status, pleural invasion, and the modified Shine–Lal index. Incorporation of the CALM index significantly enhanced model discrimination and risk reclassification at 3 and 5 years, while consistently increasing net clinical benefit across a wide range of threshold probabilities.
Conclusions
The CALM index is a biologically plausible, robust, and readily accessible prognostic biomarker that provides incremental prognostic information beyond established factors in patients with resected stage I-IIIA NSCLC. Its integration into postoperative assessment offers a framework for refined prognostic stratification and more individualized clinical decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Dongyang University, Yeongju 36040, Gyeongbuk, Republic of Korea.
- College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.
- Department of Clinical Oncology, College of Korean Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.
- Department of Thoracic Surgery, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.
ORCID-Profile: Wankyu Eo, Sookyung Lee, Dae Hyun Kim
Förderung
- Dongyang University
Zitieren
APA
An, S., Eo, W., Lee, S., & Kim, D. H. (2026). Prognostic Significance of the CALM Index in Surgically Resected Non-Small Cell Lung Cancer. Journal of Clinical Medicine, 15(15), 5772. https://doi.org/10.3390/jcm15155772
Vancouver
An S, Eo W, Lee S, Kim DH. Prognostic Significance of the CALM Index in Surgically Resected Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 2026;15(15):5772. doi:10.3390/jcm15155772
BibTeX
@article{An2026,
author = {An, Soomin and Eo, Wankyu and Lee, Sookyung and Kim, Dae Hyun},
title = {Prognostic Significance of the CALM Index in Surgically Resected Non-Small Cell Lung Cancer},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {5772},
doi = {10.3390/jcm15155772}
}
EUVIMED